AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2007
Dec 5, 2007
35599_dirs_2007-12-05_622a1180-11e0-4047-8a20-e3653aa45592.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ADHEREX TECHNOLOGIES INC (AMEX:ADH)
CIK: 0001211583
Period of Report: 2007-12-03
Reporting Person: MARTIN MICHAEL G (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-12-03 | Stock Options (Right to buy) | $0.28 | A | 50000 | Acquired | 2014-12-03 | Common Stock (50000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to buy) | $0.28 | 2014-02-28 | Common Stock (50000) | 50000 | Direct |
| Stock Options (Right to buy) | $0.34 | 2013-10-19 | Common Stock (60000) | 60000 | Direct |
| Stock Options (Right to buy) | $0.63 | 2014-04-30 | Common Stock (150000) | 150000 | Direct |
Footnotes
F1: The options to which this note relates will vest 100% on the date reported above.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20